Sumitomo Pharma Co (TSE:4506) Cyclically Adjusted Book per Share: 円1,228.02 (As of Mar. 2026)


TSE:4506 Sumitomo Pharma Co Ltd TSE:4506
65 GF Score
Price 円1,400.00
GF Value 円834.30
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sumitomo Pharma Co Cyclically Adjusted Book per Share?

Sumitomo Pharma Co TSE:4506 -2.27% 65 Cyclically Adjusted Book per Share is 円1,228.02 as of Mar. 2026. GuruFocus rates TSE:4506 with a GF Score™ of 65/100 and a GF Value™ of 円834.30 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted book value per share for the three months ended in Mar. 2026 was 円736.157. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円1,228.02 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sumitomo Pharma Co's average Cyclically Adjusted Book Growth Rate was -3.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -1.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sumitomo Pharma Co was 6.40% per year. The lowest was -1.90% per year. And the median was 4.50% per year.

As of today (2026-07-12), Sumitomo Pharma Co's current stock price is 円1400.00. Sumitomo Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円1,228.02. Sumitomo Pharma Co's Cyclically Adjusted PB Ratio of today is 1.14.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sumitomo Pharma Co was 3.70. The lowest was 0.23. And the median was 1.30.


Sumitomo Pharma Co  (TSE:4506) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sumitomo Pharma Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1400.00/1228.02
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sumitomo Pharma Co was 3.70. The lowest was 0.23. And the median was 1.30.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sumitomo Pharma Co Cyclically Adjusted Book per Share Related Terms


Sumitomo Pharma Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co Cyclically Adjusted Book per Share Chart

Sumitomo Pharma Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,203.31 1,299.71 1,309.09 1,273.02 1,228.02

Sumitomo Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,273.02 1,258.25 1,245.75 1,241.13 1,228.02

TSE:4506 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted PB Ratio falls into.


TSE:4506
65GF Score
Sumitomo Pharma Co Ltd TSE:4506
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sumitomo Pharma Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sumitomo Pharma Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=736.157/112.7000*112.7000
=736.157

Current CPI (Mar. 2026) = 112.7000.

Sumitomo Pharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 1,071.814 98.100 1,231.330
201609 1,054.223 98.000 1,212.356
201612 1,192.330 98.400 1,365.606
201703 1,037.674 98.100 1,192.109
201706 1,188.573 98.500 1,359.921
201709 1,248.480 98.800 1,424.126
201712 1,300.340 99.400 1,474.329
201803 1,139.505 99.200 1,294.579
201806 1,177.489 99.200 1,337.732
201809 1,236.102 99.900 1,394.481
201812 1,253.475 99.700 1,416.917
201903 1,253.818 99.700 1,417.305
201906 1,231.910 99.800 1,391.145
201909 1,287.865 100.100 1,449.974
201912 1,308.653 100.500 1,467.514
202003 1,340.742 100.300 1,506.497
202006 1,361.799 99.900 1,536.284
202009 1,367.933 99.900 1,543.204
202012 1,377.223 99.300 1,563.072
202103 1,461.311 99.900 1,648.546
202106 1,444.880 99.500 1,636.563
202109 1,465.685 100.100 1,650.177
202112 1,512.195 100.100 1,702.541
202203 1,530.075 101.100 1,705.633
202206 1,693.989 101.800 1,875.369
202209 1,626.366 103.100 1,777.803
202212 1,598.692 104.100 1,730.765
202303 1,023.804 104.400 1,105.198
202306 1,049.573 105.200 1,124.400
202309 1,037.038 106.200 1,100.510
202312 864.732 106.800 912.503
202403 392.818 107.200 412.972
202406 404.886 108.200 421.725
202409 287.372 108.900 297.400
202412 418.120 110.700 425.674
202503 426.588 111.100 432.731
202506 443.588 111.700 447.559
202509 668.499 112.000 672.677
202512 727.277 113.000 725.346
202603 736.157 112.700 736.157

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円1,228.02 mean?
Sumitomo Pharma Co (TSE:4506) has a Cyclically Adjusted Book per Share of 円1,228.02 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sumitomo Pharma Co and its competitors.
Is Sumitomo Pharma Co's Cyclically Adjusted Book per Share too high?
Sumitomo Pharma Co's current Cyclically Adjusted Book per Share is 円1,228.02. Overall, Sumitomo Pharma Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sumitomo Pharma Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Sumitomo Pharma Co's Cyclically Adjusted Book per Share of 円1,228.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sumitomo Pharma Co and its competitors. Sumitomo Pharma Co's current Cyclically Adjusted Book per Share is 円1,228.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sumitomo Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Sumitomo Pharma Co (TSE:4506) is currently considered Significantly Overvalued. The stock's GF Value™ is 円834.30, compared to a current price of 円1,400.00 — trading 67.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is 円1,228.02. Sumitomo Pharma Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sumitomo Pharma Co (TSE:4506), the current Cyclically Adjusted Book per Share is 円1,228.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sumitomo Pharma Co (TSE:4506) Overvalued in 2026?

Based on GuruFocus' analysis, Sumitomo Pharma Co stock appears to be overvalued. The current stock price of 円1,400.00 is trading 67.8% above its estimated GF Value™ of 円834.30. GuruFocus considers Sumitomo Pharma Co to be Significantly Overvalued.

Key valuation signals for TSE:4506:

  • Cyclically Adjusted Book per Share: 円1,228.02
  • GF Value™: 円834.30 vs. price of 円1,400.00 (67.8% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the TSE:4506 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sumitomo Pharma Co Business Description

Address 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
65GF Score

Get the complete analysis for TSE:4506

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,400.00
Price
円834.30
GF Value